Predictors of long-term outcome following high-dose chemotherapy in high-risk primary breast cancer.

Br J Cancer · 2002 · PMC2364229 · PMID 12177795

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

showed a trendP =0.06so close (0.05 < p ≤ 0.1)

OS was adversely affected by the presence of p53, high grade features, increased mitotic activity, and inflammatory presentation (stage IIIB), while overexpression of HER2/neu showed a trend ( P =0.06) toward predicting shorter survival.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.